FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

95 letters match. Newest first.

  1. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  2. Penn Herb Company, Ltd.

    FDA warned Penn Herb Company over CGMP violations and an undeclared tree-nut allergen in three dietary supplements.

    High risk
  3. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  5. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  6. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  7. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  8. Next Medical Products Company, LLC

    FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.

    High risk
  9. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk
  10. Psyched Wellness Ltd.

    FDA warned Psyched Wellness that its Calm, Calmer and Santa Amanita muscaria supplements are adulterated new-dietary-ingredient products.

    High risk
  11. Silgan Dispensing Systems

    Silgan Unicep Packaging was cited for manufacturing quality failures and unapproved new drugs after invalidated microbial tests and a fungal recall.

    High risk
  12. Jiangmen Shuizirun Sanitary Articles Co., Ltd.

    FDA warns Chinese OTC drug maker Jiangmen Shuizirun for labeling products sterile without sterilizing them or testing for sterility.

    High risk
  13. SCA Pharmaceuticals, LLC

    SCA Pharmaceuticals' sterile compounded drugs were made under unsanitary conditions with serious manufacturing violations, FDA says.

    High risk
  14. RDM Express Inc.

    FDA says RDM Express made ready-to-eat fermented cabbage under insanitary conditions and without adequate pathogen controls.

    High risk
  15. Walmart, Inc.

    Walmart sold three unapproved drugs for genital herpes and sores on walmart.com, FDA says.

    High risk
  16. The Platinum Healthcare LLC

    The Platinum Healthcare LLC sells unapproved new drugs 'Sycosis' and 'Syphillinum' online for STIs, FDA warns.

    High risk
  17. Aidance Scientific, Inc.

    FDA: Aidance Scientific's Terragen HG Formula, sold for genital sores, is an unapproved new drug.

    High risk
  18. Amazon.com, Inc.

    FDA warns Amazon over nine unapproved drugs sold on its website for genital herpes and STI symptoms.

    High risk
  19. OrganiCare, LLC / OrganiCare Nature’s Science, LLC

    FDA told OrganiCare of Austin, Texas that its HClear for him and FemiClear Genital Herpes Symptoms ointments are unapproved new drugs.

    High risk
  20. Terramed

    FDA warned Terramed that four STI-related washes and ointments are unapproved new drugs sold online.

    High risk
  21. Bioactive Services USA, LLC / Herstat Inc.

    FDA warns Bioactive Services/Herstat that Herstat GST is an unapproved new drug for genital sores.

    High risk
  22. DesBio/Deseret Biologicals, Inc.

    FDA says DesBio’s CHLA:10M, sold online for Chlamydia symptoms, is an unapproved new drug.

    High risk
  23. RoyceDerm LLC

    FDA says RoyceDerm LLC marketed Herpes Relief Cream, an unapproved new drug, for herpes symptoms on its website.

    High risk
  24. Cheap Medicine Shop/www.cheapmedicineshop.com

    FDA warned India-based website Cheap Medicine Shop for selling unapproved, misbranded injectable semaglutide to U.S. consumers.

    High risk
  25. Online Generic Medicine/www.onlinegenericmedicine.com

    FDA warned Online Generic Medicine that its website sells unapproved, misbranded injectable semaglutide to U.S. consumers.

    High risk
  26. Neogen Corporation

    FDA found Neogen's HYCOAT animal drug contaminated and made under insanitary conditions after horse deaths.

    High risk
  27. Bentley Laboratories LLC

    Bentley Laboratories LLC was cited for CGMP violations and for marketing unapproved acne drugs.

    High risk
  28. Celmade

    FDA warned Celmade over websites selling unapproved, misbranded injectable botulinum toxin products to U.S. consumers.

    High risk
  29. Stokes Healthcare Inc. dba Epicur Pharma

    FDA warned Epicur Pharma over website claims for compounded omeprazole and buprenorphine animal drugs that are false or misleading.

    High risk
  30. Wilson Livestock

    Wilson Livestock sold a heifer with excess desfuroylceftiofur residue and used a cephalosporin drug outside approved labeling for disease prevention.

    High risk
  31. Good Stuff Cacao

    FDA warns Good Stuff Cacao that disease claims make its cacao, tea, honey, goji unapproved new drugs.

    Low
  32. Advance-Esthetic LLC

    FDA says Advance-Esthetic markets three Zemits body-contouring devices without the required FDA clearance or approval.

    Medium
  33. BioDrive, Inc.

    FDA warned BioDrive that its Evolv GLP-1 Biomimetic dietary supplement is adulterated over the new dietary ingredient EV1-Peptide and safety concerns.

    High risk
  34. Binh Minh Tofu

    FDA warned Binh Minh Tofu that its ready-to-eat tofu was adulterated after a March 2026 inspection found unsafe cooling, sanitation and hygiene failures.

    High risk
  35. Peak Performance Peptides

    Peak Performance Peptides sold unapproved injectable peptide drugs, including semaglutide and retatrutide, without FDA approval.

    High risk
  36. Royal Peptides LLC

    FDA warned Royal Peptides LLC that seven peptide products sold on its website are unapproved new drugs.

    High risk
  37. TXP Innovations LLC dba Tex Peptides

    FDA warned Dallas peptide seller TXP Innovations (Tex Peptides) that its website sells unapproved injectable drugs, including semaglutide and tirzepatide.

    High risk
  38. PReye, LLC

    FDA warned PReye, LLC that its unapproved eye drop PReye Vitamin SEE was made without sterile controls in an unclassified office.

    High risk
  39. Safrel Pharmaceuticals LLC

    FDA warned Safrel Pharmaceuticals, an OTC drug labeler in Dayton, New Jersey, that it lacked quality oversight of its suppliers and shipped adulterated drugs.

    High risk
  40. Nipro Renal Solutions USA, Corporation

    Nipro Renal Solutions USA released hemodialysis dialysate lots with out-of-spec endotoxin (bacterial toxin) and had widespread quality-system failures, FDA says.

    High risk
  41. Thomas Brunner Hygiene GmbH

    Thomas Brunner Hygiene GmbH's syNeo antiperspirants are unapproved new drugs and were made without adequate manufacturing testing and validation.

    High risk
  42. Koven Technologies, Inc.

    FDA warns Koven Technologies that its Bidop 3 Doppler was labeled for fetal use without clearance and had quality system violations.

    High risk
  43. Nihon Kohden Digital Health Solutions, LLC

    FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.

    High risk
  44. Med Shop Inc / www.medshopinc.com

    FDA warned Med Shop Inc that its website sells unapproved, misbranded ketamine nasal spray to U.S. consumers.

    High risk
  45. LyfeUnit / www.lyfeunit.com

    FDA warns LyfeUnit website for selling unapproved, misbranded ketamine vials to U.S. consumers.

    High risk
  46. Amazon.com, Inc.

    FDA warned Amazon that three creams sold and shipped through Fulfillment by Amazon are unapproved new drugs for phimosis and balanitis.

    High risk
  47. Amie Health, Inc. dba Amie

    FDA warned telehealth seller Amie Health that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Medium
  48. Nova Vascular LLC dba NOVARX

    FDA warned NOVARX over false website claims that compounded semaglutide and tirzepatide products are FDA-approved or from FDA-approved pharmacies.

    Low
  49. Clover Meds LLC dba Clover Meds

    Clover Meds, a telehealth seller, misbranded compounded semaglutide and tirzepatide with false website claims that it makes the drugs and uses 'FDA-licensed' facilities.

    Medium
  50. Maximus Health, Inc. dba Maximus

    FDA warned Maximus Health that its website makes false or misleading claims about compounded semaglutide and tirzepatide.

    Low